Search results
Found 806 matches for
Big Data and Trials Delivery: Translation 2024 in a fast-changing world Day 2
General
19 April 2024
The second day of #Translation2024 began with a personal account of living with mild cognitive impairment before we dived into the complexity of data and AI.
Translation 2024 kicks off with a focus on the Blood Biomarker revolution
18 April 2024
There has never been such a high level of focus on biomarkers as we have today. It's fitting that Translation 2024 began with a look into the exciting developments which are emerging from this wave of research.
Look at the Full Programme for Translation 2024
11 April 2024
Our Translation 2024 conference is fast approaching.
DPUK secures over £4 million in challenge to find effective blood biomarkers for dementia. Could bring early diagnostic blood tests a step closer
4 April 2024
Dementias Platform UK has been awarded over £4 million to carry out countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve the UK’s shocking diagnosis rate.
DPUK at No.10 to support Dame Barbara Windsor Dementia Mission
21 March 2024
This week the DPUK executive team were thrilled to visit Downing Street to join a meeting focused on speeding up dementia research as part of the Dame Barbara Windsor Dementia Mission.
Register now: Elementary Health Data Academy 29 April – 3 May 2024
7 March 2024
We are delighted to announce bookings for our first data academy of 2024 are now open!
Our exciting speaker line-up at Translation 2024
1 March 2024
For our second year of Translation conference has a powerful programme of speakers. Gathering on 18th-19th April in London, we're bringing together the dementia research community to focus on translational developments which are taking discoveries through in-human research to biomarkers, trials and into therapeutics.
DPUK studies can help inform how the UK responds to new dementia drugs
12 February 2024
The BBC's Panorama reports that there are challenges for the NHS in offering new dementia drugs Lecanemab and Donanemab. Accurate diagnosis is vital to determine who can benefit most from these Alzheimer's drugs. Two DPUK studies are assessing the feasibility of reliable diagnoses.
ON-FIRE study begins blood sample study for frontotemporal dementia
12 February 2024
A new DPUK study of blood samples will look at genetic and environmental factors that influence immune system signatures.
Translation in a fast-changing world
18 January 2024
It is time to register for Translation 2024 - or risk missing out on our EARLYBIRD discount. The conference programme for Translation 2024 is almost complete and soon we will be revealing the full programme and list of speakers. Watch this space for more very soon.
Celebrating 2023
21 December 2023
2023 has been a highly successful year for Dementias Platform UK. Our achievements are the result of work by our teams throughout the UK who have dedicated their time, research skills and resources to Dementias Platform UK.
Save the date! Translation 2024 conference 18-19 April
8 December 2023
Dementia Platform UK is organising the second Translation conference for 18-19 April 2024. We are working on the programme of speakers and will be announcing themes and speakers shortly. You can be the first to know by signing up for our conference and DPUK News Alerts.
Grant award for DPUK work on AI Risk Evaluation
4 December 2023
DPUK has been awarded funding to investigate AI Risk Evaluation
2023 Neuroimaging Symposium
1 December 2023
DPUK's Data Portal held a symposium on neuroimaging and big data in October 2023.
DPUK helps Motor Neuron scientists with £6 million MND Accelerator programme to boost the pace of research
28 September 2023
A programme to quicken the pace of research into Motor Neuron Disease has been launched today by Dementias Platform UK which is managing the project following an investment of £6 million from the Medical Research Council and the National Institute for Health and Care Research (NIHR).
Great Minds live event in Newport on October 19
13 September 2023
Join us on October 19th in Newport or on-line for the next Great Minds Live Event, where we discuss the latest developments on new treatments for dementia, the regulatory aspects surrounding these new treatments, and how they may shape the future of dementia care. We'll also explore the impact of these developments on services provided in Brain Health and Memory Clinics.
DPUK Experts react to FDA approval of Leqembi for Alzheimer's Treatment
10 July 2023
Really exciting news! The U.S. Food and Drug Administration (FDA) has granted traditional approval to Lecanemab, a treatment for Alzheimer's disease. It opens the way for approvals in other countries around the world.
DPUK's Q2 Newsletter is Here!
7 July 2023
We have released our Q2 Newsletter, packed with all the latest updates, insights, and exciting news from our organisation.